Veterinary Medicine Information website

COLISUIN-TP ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΧΟΙΡΟΥΣ

Not authorised
  • Escherichia coli, LT toxoid
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F4ab
Download as PDF

Product identification

Medicine name:
COLISUIN-TP ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΧΟΙΡΟΥΣ
Active substance:
  • Escherichia coli, LT toxoid
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F4ab
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli, LT toxoid
    32.00
    Clinical unit
    /
    1.00
    Dose
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
    64.00
    unknown
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F5
    160.00
    unknown
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ac
    3280.00
    haemagglutinating units
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ab
    3280.00
    haemagglutinating units
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 30803/17-06-2003/K-0121801
Date of authorisation status change: